Article
Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer.
Annals of laboratory medicine - 1 Nov 2023
Cho Sun Mi, Lee Hye Sun, Jeon Soyoung, Kim Yoonjung, Kong Sun-Young, Lee Jin Kyung, Lee Kyung-A
Abstract excerpt
Background: In non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) mutation testing of tumor tissue should be conducted at diagnosis. Alternatively, circulating tumor DNA can be used to detect EGFR mutation. We compared the cost and clinical effect of three strategies according to the application of the EGFR test. Methods: Decision models were developed to compare the cost-effectiveness of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
